DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci

RT @IDJClub: Indeed, studies suggesting dalba can be cost-saving typically posit prolonged hospitalizations for IV as the alternative & wee…

Indeed, studies suggesting dalba can be cost-saving typically posit prolonged hospitalizations for IV as the alternative & weeks-long LOS reductions https://t.co/ioR0rPx8q8 https://t.co/DyPDqnvJHX https://t.co/jjXOEmhNcs https://t.co/tsFvzX9jS2 https

#ConsultPearloftheWeek Patients with BSI or IE stabilized in 🏥 and looking to simplify OPAT? 🧠 about dalbavancin. Multiple studies with good results when facilitating discharge but varied dosing strategies. What dosing do you recommend? @MK_IDpharm https:/

RT @TheIDApprentice: DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produ…